Monoclonal gammopathy of renal signifi cance: Consensus of hematologists and nephrologists of Russia on the establishment of nosology, diagnostic approach and rationale for clone specific treatment

Author:

Smirnov A. V.1ORCID,Afanasyev B. V.2ORCID,Poddubnaya I. V.3ORCID,Dobronravov V. A.1ORCID,Khrabrova M. S.4ORCID,Zakharova E. V.5ORCID,Nikitin E. A.6ORCID,Kozlovskaya L. V.7ORCID,Bobkova I. N.7ORCID,Rameev V. V.7ORCID,Batyushin M. M.8ORCID,Moiseev I. S.2ORCID,Darskaya E. I.2,Pirogova O. V.2,Mendeleeva L. P.9ORCID,Biryukova L. S.10

Affiliation:

1. Scientific Research Institute of Nephrology; Pavlov First St-Petersburg State Medical University

2. Raisa Gorbacheva Memorial Research Institute of Children Oncology, Hematology and Transplantation; Pavlov First St-Petersburg State Medical University

3. Russian Medical Academy of Postgraduate Education

4. Pavlov First St-Petersburg State Medical University

5. A.I. Yevdokimov Moscow State University of Medicine and Dentistry; Russian Medical Academy of Postgraduate Education; Nephrology Department, City Botkin Memorial Hospital

6. Russian Medical Academy of Postgraduate Education; City Botkin Memorial Hospital

7. I.M. Sechenov First Moscow State Medical University (Sechenov University)

8. Rostov State Medical University

9. National Research Center of Hematology

10. Russian Medical Academy of Postgraduate Education; National Research Center of Hematology

Abstract

Monoclonal gammopathy of renal significance (MGRS) is a new nosology in modern nephrology and oncohematology. MGRS is defined as kidney injury due to nephrotoxic monoclonal immunoglobulin produced by the B-cell line clone which does not reach the hematological criteria for specific treatment initiation. Monoclonal protein’s pathological effects on kidney parenchyma result in irreversible decline of kidney function till the end stage renal disease that in line with the position of International Consensus of hematologists and nephrologists determinates critical necessity for clone specific treatment in patients with MGRS despite the absence of hematological indications for treatment initiation. Main challenge of MGRS in Russian Federation is an inaccessibility of an in-time diagnostic and appropriate treatment for the great majority of patients due to the following reasons: i) limited knowledge about the MGRS among hematologists and nephrologists; ii) lack of necessary diagnostic resources in most health-care facilities; iii) lack of approved clinical recommendations and medical economic standards for treatment of this pathological entity. Consensus document comprises the opinion of experts – leading nephrologists and hematologists of Russian Federation – on the problem of MGRS including the incoherence in nosology classification, diagnostics approach and rationale for clone specific treatment. Consensus document is based on conclusions and agreements reached during the conference of leading nephrologists and hematologists of Russia which was held in the framework of symposia «Plasma cell dyscrasias and lymphoproliferative diseases: modern approaches to therapy», 15-16 of March 2019, Pavlov First St-Petersburg State Medical University, St-Petersburg, Russia. The present Consensus is intended to define the principal practical steps to resolve the problem of MGRS in Russian Federation that are summarized as final clauses.

Publisher

Non-profit organization Nephrology

Subject

Nephrology

Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3